Access cutting-edge crohn disease treatment through this clinical trial at a research site in Charlestown. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Charlestown location
Preparing your pre-screening questions…
Access crohn disease specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related crohn disease treatment provided free
Check if you qualify for this crohn disease clinical trial in Charlestown, MA
No-Cost Study Care
Local to Charlestown
Convenient for MA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
In this study twenty-five (25) subjects with Crohn's disease scheduled for possible surgical intervention will be recruited for this study and a PET/MR scan using the collagen-binding radiotracer will be performed. The study aims to establish the performance figures of PET/MR using \[68Ga\]CBP8-PET for preoperative detection and differentiation of strictures with a fibrotic component in patients with Crohn's disease by using surgical and histologic findings (when available) as the standard for comparison. Furthermore, the investigators will determine the performance figures with which strictures are identified and characterized by PET/MR using \[68Ga\]CBP8-PET compared to each modality in isolation (PET alone or MR alone). Blood and tissue markers for fibrostenosis will be explored (either predictive or as biomarkers for fibrotic burden), using histologic and molecular testing by using surgical and histologic findings (when available) as the standard for comparison. Lastly the investigators want to determine the performance figures with which strictures are identified and characterized by PET/MR using \[68Ga\]CBP8-PET compared to each modality in isolation (PET alone or MR alone).
Sponsor: Massachusetts General Hospital
Yes, this clinical trial (NCT06252493) has an active research site in Charlestown, MA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for crohn disease treatment options in Charlestown, MA, this clinical trial (NCT06252493) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Charlestown research site is actively enrolling participants for this clinical trial. You'll receive care from experienced crohn disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all crohn disease clinical trials near you to find additional studies recruiting in your area.
See all crohns disease clinical trials recruiting in Charlestown — not just this study.
Browse Crohns Disease Trials in Charlestown →